Literature DB >> 26430672

Massive hemoperitoneum due to a ruptured corpus luteum cyst in a patient with congenital hypofibrinogenemia.

Jong-Hyun Kim1, So-Young Jeong1, Dong-Hyu Cho1.   

Abstract

Congenital afibrinogenemia/hypofibrinogenemia is a rare inherited hematologic disorder in which a patient lacks or has insufficient level of fibrinogen, the blood coagulation factor I. The incidence of this uncommon disease is 1 to 2 per 1 million individuals. Hence, massive hemoperitoneum caused by ovulation in a woman with congenital afibrogenemia is also a very rare clinical condition. Massive hemoperitoneum usually presents as acute abdominal pain with potential findings of peritonitis including abdominal distention, hypotension and tachycardia with critical consequences. We performed emergent endoscopic surgery for hemoperitoneum caused by a ruptured corpus luteum cyst in a patient with congenital hypofibrinogenemia. To the best of our knowledge, this was the first case report of such treatment in Korea.

Entities:  

Keywords:  Afibrinogenemia; Hemoperitoneum; Hypofibrinogenemia congenital; Ovarian cysts; Rupture

Year:  2015        PMID: 26430672      PMCID: PMC4588852          DOI: 10.5468/ogs.2015.58.5.427

Source DB:  PubMed          Journal:  Obstet Gynecol Sci        ISSN: 2287-8572


  10 in total

Review 1.  The rare coagulation disorders--review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation.

Authors:  P H B Bolton-Maggs; D J Perry; E A Chalmers; L A Parapia; J T Wilde; M D Williams; P W Collins; S Kitchen; G Dolan; A D Mumford
Journal:  Haemophilia       Date:  2004-09       Impact factor: 4.287

Review 2.  Spontaneous hemoperitoneum: causes and significance.

Authors:  Brian C Lucey; Jose C Varghese; Jorge A Soto
Journal:  Curr Probl Diagn Radiol       Date:  2005 Sep-Oct

3.  Incidence of bleeding symptoms in 100 patients with inherited afibrinogenemia or hypofibrinogenemia.

Authors:  F Peyvandi; S Haertel; S Knaub; P M Mannucci
Journal:  J Thromb Haemost       Date:  2006-07       Impact factor: 5.824

4.  Budd-Chiari syndrome in an afibrinogenemic patient: a paradoxical complication.

Authors:  Nevin Oruc; Yaman Tokat; Refik Killi; Murat Tombuloglu; Tankut Ilter
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

5.  Congenital afibrinogenemia: successful prevention of recurrent hemoperitoneum during ovulation by oral contraceptive.

Authors:  G Castaman; M Ruggeri; F Rodeghiero
Journal:  Am J Hematol       Date:  1995-08       Impact factor: 10.047

Review 6.  The molecular basis of quantitative fibrinogen disorders.

Authors:  R Asselta; S Duga; M L Tenchini
Journal:  J Thromb Haemost       Date:  2006-10       Impact factor: 5.824

7.  Prevention of hemoperitoneum during ovulation by oral contraceptives in women with type III von Willebrand disease and afibrinogenemia. Case reports.

Authors:  E Bottini; F I Pareti; D Mari; P M Mannucci; M L Muggiasca; M Conti
Journal:  Haematologica       Date:  1991 Sep-Oct       Impact factor: 9.941

8.  Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. A United Kingdom Haemophilia Center Doctors' Organisation (UKHCDO) guideline approved by the British Committee for Standards in Haematology.

Authors:  D Keeling; C Tait; M Makris
Journal:  Haemophilia       Date:  2008-04-04       Impact factor: 4.287

9.  Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias.

Authors:  S S Acharya; A Coughlin; D M Dimichele
Journal:  J Thromb Haemost       Date:  2004-02       Impact factor: 5.824

Review 10.  Recessively inherited coagulation disorders.

Authors:  Pier Mannuccio Mannucci; Stefano Duga; Flora Peyvandi
Journal:  Blood       Date:  2004-05-11       Impact factor: 22.113

  10 in total
  2 in total

Review 1.  Clinical Consequences and Molecular Bases of Low Fibrinogen Levels.

Authors:  Marguerite Neerman-Arbez; Alessandro Casini
Journal:  Int J Mol Sci       Date:  2018-01-08       Impact factor: 5.923

Review 2.  Women With Congenital Hypofibrinogenemia/Afibrinogenemia: From Birth to Death.

Authors:  Yan Zhang; Xiaohang Zuo; Yue Teng
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.